Endocrine and multiple sclerosis outcomes in patients with autoimmune thyroid events in the alemtuzumab CARE-MS studies.

Colin M DayanBeatriz LecumberriIlaria MullerSashiananthan GanesananthanSamuel F HunterKrzysztof W SelmajHans-Peter HartungEva K HavrdovaChristopher C LaGankeTjalf ZiemssenBart Van WijmeerschSven G MeuthDavid H MargolinElizabeth M PooleDarren P BakerPeter A Senior

Published in: Multiple sclerosis journal - experimental, translational and clinical (2023)

CARE-MS I (NCT00530348); CARE-MS II (NCT00548405); CARE-MS Extension (NCT00930553).

Keyphrases

multiple sclerosis
healthcare
mass spectrometry
palliative care
ms ms
quality improvement
white matter
adipose tissue
chronic pain
weight loss
insulin resistance